Skip to main content
SpringerLink
Log in
Book cover

Die koronare Herzkrankheit der Frau pp 67–92Cite as

Risikofaktoren der KHK und Möglichkeiten ihrer Reduzierung

  • Chapter

  • 86 Accesses

Zusammenfassung

In den Industrienationen ist die koronare Herzkrankheit (KHK) die häufigste Todesursache. Daher ist die Prävention der KHK eine wichtige gesundheitspolitische Aufgabe. Bei der Primärprävention geht es um die Verhütung kardiovaskulärer Ereignisse vor der klinischen Manifestation, bei der Sekundärprävention um die Verhütung weiterer Ereignisse bei Patienten mit bereits manifester KHK. Bei der Primärprävention unterscheidet man die Hochrisikostrategie von der Bevökerungsstrategie. Im ersten Fall sollen Menschen mit stark erhöhtem kardiovaskulären Risiko (z.B. Diabetiker, genetisch Belastete) identifiziert werden, um sie gezielt einer geeigneten Therapie zuzuführen. Im anderen Fall wird die gesamte Bevölkerung über häufige und vermeidbare Risikofaktoren (z.B. Rauchen, Übergewicht, Fehlernährung, Bewegungsarmut) aufgeklärt und zu deren Beseitigung bzw. Korrektur motiviert [12, 25, 33].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alberti KGMM, Zimmer PT (1998) Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetes Med 15:539–553

    Article  CAS  Google Scholar 

  2. American Diabetes Association (1999) Clinical Practice recommendations Diabetes Care 22(Suppl 1):S1–S114

    Google Scholar 

  3. Barrett-Connor E, Grady D (1998) Hormone replacement therapy, heart disease, and other considerations. Ann Rev Public Health 19:55–72

    Article  CAS  Google Scholar 

  4. Bolibar I, Eckardstein A von, Assmann G, Thompson S on behalf of the ECAT Angina Pectoris Study Group (2000) Short-term prognostic value of lipid measurements for coronary events in patients with angina pectoris. Thromb Haemost 84:955–960

    PubMed  CAS  Google Scholar 

  5. DeFronzo RA (1999) Pharmacologic therapy for type 2 diabetes mellitus. Ann Int Med 17(131):281–303

    Google Scholar 

  6. Depka M von, Nowak-Gottl U, Eisert R, Dieterich C, Bartheis M, Scharrer I, Ganser A, Ehrenforth S (2000) Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 96:3364–3368

    Google Scholar 

  7. Eckardstein A von, Assmann G (2000) Kardiovaskuläre Wirkungen und Einfluß auf den Lipidstoffwechsel von substitutiven Steroiden. In: Fischl FH, Huber JH (Hrsg) Menopause — Andropause: Die Hormonsubstitution im Wandel der Zeit Krause & Pachernegg GmbH, Gablitz, S 119–132

    Google Scholar 

  8. Eckardstein A von, Assmann G (2000) Prevention of coronary heart disease by raising of HDL cholesterol? Curr Opin Lipidol 11:627–637

    Article  Google Scholar 

  9. Eckardstein A von, Huang Y, Assmann G (1994) Physiological role and clinical relevance of high density lipoprotein subclasses. Curr Opin Lipidol 5:404–416

    Article  Google Scholar 

  10. Eckardstein A von, Nofer JR, Assmann G (2001) HDL and coronary heart disease: Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 20:13–27

    Article  Google Scholar 

  11. Eckardstein A von, Schulte H, Cullen P, Assmann G (2001) Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk J Am Coll Cardiol 37:2434–2439

    Google Scholar 

  12. Expert Panel ion detection, evaluation and treatment of high blood cholestreol in adults (Grundy SM, chairman) (1994) The second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 89:1329–1445

    Google Scholar 

  13. Funke H, Assmann G (1999) Strategies for the assessment of genetic coronary artery disease risk. Curr Opin Lipidol 10:285–291

    Article  PubMed  CAS  Google Scholar 

  14. Giral P, Bruckert E, Jacob N, Chapman MJ, Foglietti M, Turpin G (2001) Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia. Atherosclerosis 154:421–427

    Article  PubMed  CAS  Google Scholar 

  15. Gordon D, Rifkind BM (1989) Current concepts: high density lipoproteins — the clinical implications of recent studies. N Engl J Med 321:1311–1315

    Article  PubMed  CAS  Google Scholar 

  16. Gould AL, Rossouw JE, Santanello NC, Heyse J, Furberg CD (1998) Cholesterol reduction yields clinical benefit. Impact of statin trials. Circulation 97:946–952

    Article  PubMed  CAS  Google Scholar 

  17. Grady D, Rubin SN, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Annual Internal Medicine 117:1016–1037

    CAS  Google Scholar 

  18. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V (1999) Assessment of Cardiovascular risk by use of multipe-risk factor assessment equations. A statement for health care professionals from the American Heart Association and the American College of Cardiology. Circulation 100:1481–1492

    Article  PubMed  CAS  Google Scholar 

  19. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339(4):229–234

    Article  PubMed  CAS  Google Scholar 

  20. Hobbs HH, White AL (1999) Lipoprotein(a): intrigues and insights. Curr Opin Lipidol 10:225–236 (Review)

    Article  PubMed  CAS  Google Scholar 

  21. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risc 3:213–219

    Article  CAS  Google Scholar 

  22. Holvoet P, Collen D, Van de Werf F (1999) Malondialdehyde-modified LDL as a marker of acute coronary syndromes. JAMA 281:1718–1721

    Article  PubMed  CAS  Google Scholar 

  23. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605–613

    Article  PubMed  CAS  Google Scholar 

  24. Hypertension Control Report of a WHO Expert Committee (1996) WHO Technical Report Series No. 862, Worl Health Organization, Geneva

    Google Scholar 

  25. International Task Force for Prevention of Coronary Heart Disease (1998) Coronary heart disease: Reducing the risk. The scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. Nutr Metab Cardiovasc Dis 8:205–271

    Google Scholar 

  26. Lamarche B, Tchernof A, Mauriege P, Cantin B, Dagenais GR, Lupien PJ, Despres JP (1998) Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279:1955–1961

    Article  PubMed  CAS  Google Scholar 

  27. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, Schaefer EJ (2001) Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the framingham heart study. Atherosclerosis 154:229–236

    Article  PubMed  CAS  Google Scholar 

  28. Nowak-Göttl U, Junker R, Eckardstein A von, Kosch A, Nohe N, Schobess R, Ehrenforth S, Kruz WD (2001) Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 97:858–862

    Article  PubMed  Google Scholar 

  29. Packard C, Caslake M, Shepherd J (2000) The role of small, dense low density lipoprotein (LDL): a new look. Int J Cardiol 74(Suppl 1):S17–22

    Article  Google Scholar 

  30. Rader DJ, Hoeg JM, Brewer HB (1994) Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 120:1012–1025 (Review)

    PubMed  CAS  Google Scholar 

  31. Ridker PM (1999) Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med 130:933–937

    PubMed  CAS  Google Scholar 

  32. Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB (2000) Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA 283:1845–1852

    Article  PubMed  CAS  Google Scholar 

  33. Task Force Report (1998) Prevention of coronary heart disease in clinical practice: Recommendations of the second joint task force of European and Other Societies on coronary prevention. Atherosclerosis 140:199–270

    Article  Google Scholar 

  34. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 20:1183–1197

    Google Scholar 

  35. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of high blood pressure (1997) Arch Intern Med 157:2413–2446

    Article  Google Scholar 

  36. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131):837–853

    Article  Google Scholar 

  37. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338: 1042–1050

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. von Eckardstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Schulte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Assmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum Coburg II. Med. Klinik — Kardiologie, Ketschendorfer Str. 33, 96450, Coburg, Deutschland

    Johannes Brachmann  & Hans Jochen Medau  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

von Eckardstein, A., Schulte, H., Assmann, G. (2002). Risikofaktoren der KHK und Möglichkeiten ihrer Reduzierung. In: Brachmann, J., Medau, H.J. (eds) Die koronare Herzkrankheit der Frau. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57534-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57534-1_7

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63290-7

  • Online ISBN: 978-3-642-57534-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation